DermTopic: Psoriasis

Filter Your Results

 

News

 

Stelara Adds New Approval: Crohn's Disease

The FDA has approved STELARA® (ustekinumab) from Janssen Biotech, Inc., for the treatment of moderately to severely …

FDA Approves Humira Biosimilar

The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) f…

Therapeutics Focus: Psoriasis

FDA Approves Enbrel Biosimilar The FDA approved Erelzi for multiple inflammatory diseases. Erelzi is a biosimilar to …

Save the Date: Sept 28th Marks First Ever PsA Awareness Day

September 28th marks the first-ever Psoriatic Arthritis (PsA) Awareness Day. Launched by Celgene Corporation and the …

Allergan Bolsters Medical Derm Portfolio with Vitae Acquisit…

Allergan plc is acquiring Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company. The move will serve to…

DermWireTV: Patient Outreach Initiatives; Erelzi Approved

DermatologistOnCall® Partners with NPF to enhance access to care for psoriasis. Vivacare Partners with NRS for patient …

DermWire.com

Santalis Pharmaceuticals Starts Phase 2 Study of New Sandalw…

Santalis Pharmaceuticals has enrolled the first patient in a Phase 2 Study of 5% East Indian Sandalwood O…

FDA Approves Enbrel Biosimilar

The U.S. Food and Drug Administration (FDA) approved Erelzi for multiple inflammatory diseases. Erelzi is a biosimilar t…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.